Leptin: primary central site of action?
Adam
Clare L
CL
Obesity & Metabolic Health Division, Rowett Institute of Nutrition & Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, UK. c.adam@abdn.ac.uk
D000818:Animals; D001066:Appetite / Q000187:drug effects* / Q000502:physiology; D001111:Arcuate Nucleus of Hypothalamus / Q000503:physiopathology* / Q000601:surgery; D005260:Female; D007031:Hypothalamus / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D007150:Immunohistochemistry; D020738:Leptin / Q000494:pharmacology*; D009474:Neurons / Q000737:chemistry / Q000166:cytology / Q000187:drug effects; D009478:Neuropeptide Y / Q000032:analysis; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis; D012756:Sheep
D020738:Leptin; D009478:Neuropeptide Y; D016760:Proto-Oncogene Proteins c-fos